Farther Finance Advisors
ARCT icon

Farther Finance Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Farther Finance Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.8K Buy
789
+234
+42% +$2.44K ﹤0.01% 4568
2026
Q2 		$3.76K Buy
555
+226
+69% +$1.78K ﹤0.01% 4935
2026
Q1 		$2.58K Buy
329
+39
+13% +$285 ﹤0.01% 4795
2025
Q4 		$1.78K Sell
290
-95
-25% -$1.03K ﹤0.01% 4738
2025
Q3 		$7.1K Buy
385
+121
+46% +$1.94K ﹤0.01% 3603
2025
Q2 		$3.44K Buy
+264
New +$3.12K ﹤0.01% 3513
2025
Q1 		– Sell
-47
Closed -$798 – 4273
2024
Q4 		$798 Sell
47
-23
-33% -$433 ﹤0.01% 3316
2024
Q3 		$1.63K Buy
70
+1
+1% +$21 ﹤0.01% 3069
2024
Q2 		$1.63K Buy
69
+18
+35% +$546 ﹤0.01% 2871
2024
Q1 		$1.69K Hold
51
– – ﹤0.01% 2556
2023
Q4 		$1.61K Buy
+51
New +$1.21K ﹤0.01% 2519

Other funds holding ARCT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

Farther Finance Advisors's ARCT Position: Q3 2026 in Review

Farther Finance Advisors increased its Arcturus Therapeutics (ARCT) stake by 42% in Q3 2026, buying an estimated $2.44K and bringing the position to 789 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4568.

Farther Finance Advisors first reported a position in ARCT in Q4 2023 and has held it in 11 quarters since. 10 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • Farther Finance Advisors held 789 shares of Arcturus Therapeutics worth $10.8K as of Q3 2026.
  • Farther Finance Advisors bought 234 Arcturus Therapeutics shares in Q3 2026, an estimated $2.44K.
  • Arcturus Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4568 holding.
  • Farther Finance Advisors first reported a position in Arcturus Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 10 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.